InhaleRx Limited (ASX:IRX) Executes Study Order for Phase 2 IRX-211 Trial
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
Category: ASX-IRX
InhaleRx Limited
Latest News
InhaleRx Limited (ASX:IRX) Executes Study Order for Phase 2 IRX-211 Trial
Silver Mines Limited (ASX:SVL) Begins Drilling at Elsienora Project
Carbonxt Group Limited (ASX:CG1) Restructures Black Birch Lease and Secures 37% Premium Placement
Nine Entertainment Co. (ASX:NEC) Appoints Matthew Stanton as CEO
Silk Logistics Holdings Limited (ASX:SLH) Announces ACCC Statement of Issues for Acquisition Scheme
Helios Energy Limited (ASX:HE8) Announces Placement and Entitlement Offer
Thor Energy PLC (ASX:THR) Converts Exploration Licence
Global Uranium and Enrichment Limited (ASX:GUE) Secures A$10.0m Placement for Pine Ridge Uranium Project
Silk Logistics Holdings Limited (ASX:SLH) Acquisition by DP World Australia Faces ACCC Scrutiny
Resolution Minerals Ltd (ASX:RML) Completes $1.7 Million Placement
The Hub of Australian Finance News